Girish Aakalu
Corporate Officer/Principal presso GENOCEA BIOSCIENCES, INC.
Provenienza dei contatti di primo grado di Girish Aakalu
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Public Company | Biotechnology | 16 | |
Phenomic AI, Inc.
Phenomic AI, Inc. Packaged SoftwareTechnology Services Phenomic AI, Inc. develops machine-learning technology for drug discovery. It provides application of deep learning to biological imaging screens and chemo-informatics. The company was founded by Oren Kraus and Sam Cooper and is headquartered in Toronto, Canada.
3
| Holding Company | Packaged Software | 3 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Girish Aakalu tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
AMGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Georgetown University | College/University | Doctorate Degree Masters Business Admin | |
ADAPTIMMUNE THERAPEUTICS PLC | Biotechnology | Director/Board Member Corporate Officer/Principal | |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Medical/Nursing Services | Corporate Officer/Principal Corporate Officer/Principal | |
BIOGEN INC. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
American Association for Cancer Research
American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
The University of Chicago | College/University | Masters Business Admin Doctorate Degree | |
ARCELLX, INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
VAXART, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
ARIAD PHARMACEUTICALS, INC. | Biotechnology | Corporate Officer/Principal | |
Lehigh University | College/University | Undergraduate Degree | |
ADC THERAPEUTICS SA | Pharmaceuticals: Major | Corporate Officer/Principal | |
IMMUNOGEN, INC. | Biotechnology | Corporate Officer/Principal | |
MORPHOSYS AG | Biotechnology | President | |
Gwynedd-Mercy Academy | Director/Board Member | ||
CHEMOCENTRYX, INC. | Pharmaceuticals: Major | Director/Board Member | |
St. Francis Xavier University | College/University | Undergraduate Degree | |
Albireo Ltd.
Albireo Ltd. Pharmaceuticals: MajorHealth Technology Albireo Ltd. develops therapies that address medical needs in the gastrointestinal and liver disease area. It is a biotechnology company that develops therapies that address unmet medical needs in the gastrointestinal area and liver disease area. The firm's programs include Cholestatic Liver Diseases; Bile Acid Mal-absorption; Type 2 Diabetes Mellitus; Atopic Dermatitis and Psoriasis; and Post-Operative Adhesions. The company was founded by Jan Peter Mattsson in February 2008 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
IOVANCE BIOTHERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal | |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director of Finance/CFO | |
International BioResources Group
International BioResources Group Miscellaneous Commercial ServicesCommercial Services International BioResources Group is a biological and life science research firm. The private company is based in Manassas, VA. The CEO of the company is Raymond H. Cypess. | Miscellaneous Commercial Services | President | |
Washington University in St. Louis | College/University | Undergraduate Degree | |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Ipsen Biopharmaceuticals, Inc. | Chief Tech/Sci/R&D Officer | ||
PEPGEN INC. | Biotechnology | Director/Board Member | |
St. Michael's College | College/University | Undergraduate Degree | |
Stony Brook University | College/University | Doctorate Degree | |
Roche Pharmaceuticals, Inc.
Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
FIVE PRIME THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer | |
University of Michigan | College/University | Masters Business Admin | |
American Type Culture Collection
American Type Culture Collection BiotechnologyHealth Technology American Type Culture Collection operates as a global biological materials resource and standards organization offering a collection of products and services. Its services include production and characterization, testing, biorepository, and deposit. The company was founded in 1925 and is headquartered in Manassas, VA. | Biotechnology | President | |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal | |
ALZA CORPORATION | Pharmaceuticals: Major | Corporate Officer/Principal | |
KAHR Medical Ltd.
KAHR Medical Ltd. Pharmaceuticals: MajorHealth Technology KAHR Medical Ltd. develops novel fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases. Its drug pipeline is built around the signal converter proteins a unique class of multi-functional therapeutic agents that convert signals sent from one cell to another. The firm?s therapeutic proteins integrate two functional units, enabling each one to elicit multiple cooperative functional endpoints. The company was founded by Mark L. Tykocinski in 2005 and is headquartered in Jerusalem, Israel. | Pharmaceuticals: Major | Chairman | |
Aulos Bioscience, Inc.
Aulos Bioscience, Inc. BiotechnologyHealth Technology Aulos Bioscience, Inc. operates as a biotechnology firm. The company is headquartered in Cambridge, MA. | Biotechnology | Chief Executive Officer | |
RAYZEBIO, INC. | Biotechnology | Chief Executive Officer | |
THERIVA BIOLOGICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
University of Tennessee | College/University | Doctorate Degree | |
University of Mary Washington | College/University | Undergraduate Degree | |
ALBIREO PHARMA, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
Albireo AB
Albireo AB Pharmaceuticals: MajorHealth Technology Albireo AB operates as a biopharmaceutical company, which focuses on the development and potential commercialization of novel bile acid modulators. It helps treat orphan pediatric liver diseases and gastrointestinal disorders where the improper flow or absorption of bile causes serious medical conditions for which there is high unmet need. The company was founded by Per-Göran Gillberg and Jan Mattsson and is headquartered in Göteborg, Sweden. | Pharmaceuticals: Major | Chief Executive Officer | |
BioTheryX, Inc.
BioTheryX, Inc. Pharmaceuticals: MajorHealth Technology BioTheryX, Inc. pengages in the development of clinical drugs. It focuses on the restoration of protein homeostasis, including protein degradation and modulation, and multi-kinase inhibition. The company was founded by David I. Stirling and Lawrence Zaslow in 2007 and is headquartered in Chappaqua, NY. | Pharmaceuticals: Major | Director/Board Member | |
GENERATION BIO CO. | Pharmaceuticals: Major | Director/Board Member | |
University of Wisconsin | College/University | Graduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 44 |
Regno Unito | 3 |
Svizzera | 2 |
Germania | 2 |
Canada | 2 |
Settori
Health Technology | 32 |
Consumer Services | 13 |
Commercial Services | 4 |
Health Services | 2 |
Posizioni
Director/Board Member | 72 |
Corporate Officer/Principal | 50 |
Independent Dir/Board Member | 32 |
Chief Tech/Sci/R&D Officer | 25 |
Undergraduate Degree | 15 |
Contatti più connessi
Insiders | |
---|---|
Ali Behbahani | 34 |
Ken Bate | 19 |
Ruchita Sinha | 18 |
Howard Mayer | 16 |
Gisela Schwab | 12 |
Jennifer Herron | 12 |
Aron M. Knickerbocker | 11 |
Jessica Flechtner | 11 |
Raymond Stapleton | 9 |
Thomas Andrew Davis | 9 |
Diantha Duvall | 8 |
Narinder Singh | 8 |
Ronald Cooper | 7 |
Thomas Heineman | 7 |
Jacquelyn Sumer | 6 |
- Borsa valori
- Insiders
- Girish Aakalu
- Connessioni Società